According to the Bing Covid-19 Tracker, global confirmed cases have reached 6,075,786. Active cases were 3,134,460, up 69,776 Active cases are 52% of the total of confirmed cases worldwide. Recovered cases were 2,571,797, a…
According to the Bing COVID-19 Tracker, the number of global cases has reached 5,919,364. It is probably only a day or so from reaching 6 million. Active cases rose by 20,306 since yesterday to 3,064,684,…
While Amarin supports research into Vascepa's possible use in treating COVID-19, the financial benefits promise to be greater if Vascepa's patents are upheld. Of course, Wall Street is bound to lift the share price…
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
Phio Pharmaceuticals shares more than doubled on Friday after the firm announced positive data from its cancer study at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program.
Adaptimmune Therapeutics shares jumped on Friday after the company announced updated data from its early-stage clinical trial in patients with lung, head and neck cancers.
According to the Bing COVID-19 Tracker, the number of global cases has reached 5,803,416. Active cases rose by 59,369 to 3,044,378 and are 53% of the total of confirmed cases worldwide. Recovered cases totaled…
PhaseBio Pharmaceuticals shares jumped early on Thursday after the company announced that it received an authorization from the FDA regarding its COVID-19 treatment.
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
According to the Bing COVID-19 Tracker, the number of global cases has reached 5,690,182 and is likely to hit 5.7 million within a day. Active cases rose by 31,552 to 2,985,009. They are 53%…
In a world where investors are starving to find growth, many of the well established biotech leaders and many of the large pharmaceutical companies have been acquiring growth on top of their own existing…
Amarin’s Vascepa treats cardiovascular disease, which is a big risk factor for COVID-19 patients, but is the subject of patent litigation.
Mersana Therapeutics shares jumped on Wednesday after the company reported interim results from its early-stage cancer study.
According to the Bing COVID-19 Tracker, the number of global cases has reached 5,591,067 and is likely to hit 5.6 million in a day. Active cases rose by 41,447 to 2,953,457, and they are…
Atara Biotherapeutics finds itself caught between a rock and a hard place after Friday's drug study news concerning its treatment for multiple sclerosis.
